Premium
Comparison of 0.2% ropivacaine and 0.25% bupivacaine for axillary brachial plexus blocks in paediatric hand surgery
Author(s) -
Thornton K.L.,
Sacks M.D.,
Hall R.,
Bingham R.
Publication year - 2003
Publication title -
pediatric anesthesia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.704
H-Index - 82
eISSN - 1460-9592
pISSN - 1155-5645
DOI - 10.1046/j.1460-9592.2003.01065.x
Subject(s) - medicine , bupivacaine , ropivacaine , brachial plexus , anesthesia , surgery , analgesic , brachial plexus block , axilla , nerve block , breast cancer , cancer
Summary Background: The purpose of this study was to compare the use of ropivacaine 0.2% with bupivacaine 0.25% for axillary brachial plexus block in children undergoing hand surgery. Methods: In a double‐blind, randomized study, 35 children undergoing hand surgery received axillary brachial plexus blocks with 0.5 ml·kg −1 of either 0.2% ropivacaine or 0.25% bupivacaine. Pain scores were noted at 0, 3, 6, 12 and 24 h after surgery. The time to first dose of codeine phosphate and the total doses of all analgesics given were recorded. Results: There was no significant difference between the two groups in pain scores, the time to first dose of codeine phosphate or in analgesic requirements in the first 24 h. Conclusions: Ropivacaine 0.2% is as effective as bupivacaine 0.25% for axillary brachial plexus blocks in children undergoing hand surgery.